Salicylic acid for the treatment of melasma: New acquisitions for monitoring the clinical improvement

Skin Research and Technology

Volumn 19, Issue 4, 2013, Pages 466-473

  Fabbrocini, Gabriella ^a   De Vita, Valerio ^a   Marasca, Claudio ^a   Palmisano, Franco ^a   Monfrecola, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Chemical peel; Digital images; Hyperpigmentation; MASI; Melasma; Salicylic acid

Indexed keywords

CLINICAL ASSESSMENTS; CLINICAL OBSERVATION; DIGITAL IMAGE; DIGITAL PHOTOGRAPHS; HYPERPIGMENTATION; MASI; MELASMA; OBSERVATIONAL STUDY;

IMAGE PROCESSING;

SALICYLIC ACID;

SALICYLIC ACID;

ADULT; ARTICLE; CHLOASMA; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DERMATOLOGIST; DIGITAL IMAGING; FEMALE; HUMAN; OBSERVATIONAL STUDY; PHOTOGRAPHY; SCORING SYSTEM;

CHEMICAL PEEL; DIGITAL IMAGES; HYPERPIGMENTATION; MASI; MELASMA; SALICYLIC ACID;

ADULT; CHEMEXFOLIATION; DRUG MONITORING; EPIDERMIS; FACE; FEMALE; HUMANS; KERATOLYTIC AGENTS; LINEAR MODELS; MELANOSIS; MIDDLE AGED; MODELS, BIOLOGICAL; PHOTOGRAPHY; SALICYLIC ACID; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84885471877     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/srt.12070     Document Type: Article

References (22)

1. Pasricha JS, Khaitan BK, Dash S. Pigmentary disorders in India. Dermatol Clin 2007; 25: 343-522.
2. Sivayathorn A. Melasma in orientals. Clin Drug Investig 1995; 10(Suppl. 2): 24-40.
3. Miot LDB, Miot HA, Da Silva MG, Marques MEA. Physiopathology of melasma. An Bras Dermatol 2009; 84: 623-635.
4. Lapeere H, Borne B, Schepper S, Verhaeghe E, Ongenae K, Geel NV. Hypomelanosis and hypermelanosis. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS and Leffell DJ, eds. Dermatology in general medicine, 7th edn. New York: McGraw-Hill; 2008: 622-640.
5. Karen JK, Pomeranz MK. Skin changes and diseases in pregnancy. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS and Leffell DJ, eds. Dermatology in general medicine, 7th edn. New York: McGraw-Hill; 2008: 955-962.
6. Ayala F, Lisi P, Monfrecola G. Vitiligine e altri disturbidella pigmentazione. In: Ayala F, Lisi P, Monfrecola G eds. Malattie cutanee e veneree. Padova: Piccin; 2007: 265-271.
7. Goldberg DJ, Berlin AL, Phelps R. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Lasers Surg Med 2008; 40: 134-138.
8. Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004; 17: 96-110.
9. Balkirashnan R, Michael AM, Camatcho FT et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003; 149: 572-577.
10. Grimes P. Melasma: ethiologic and therapeutic consideration. Arch Dermatol 1995; 131: 1453-1457.
11. Khemis A, Kaiafa C, Queille-Roussel L, Duteil L, Ortonne JP. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. Br J Dermatol 2007; 156: 997-1004.
12. Kim SJ, Son KH, Chang HW, Kang SS, Kim HP. Tyrosinase inhibitory prenylated flavonoids from Sophora flavescens. Biol Pharm Bull 2003; 26: 1348-1350.
13. Manaloto RM, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg 1999; 25: 121-123.
14. Nouri K, Bowes L, Chartier T, Romagosa R, Spencer J. Combination treatment of melasma with pulsed CO2 laser followed by Qswitched alexandrite laser: a pilot study. Dermatol Surg 1999; 25: 494-497.
15. Alster Ts. Extended clinical experience with Erbium:YAG cutaneous laser resurfacing. Lasers Surg Med 1998; 23: 34-39.
16. Fabbrocini G, De Vita V, Fardella N et al. Skin needling to enhance depigmenting serum penetration in the treatment of melasma. Plast Surg Int 2011; 2011: 158241.
17. Rendon MI, Berson DS, Cohen JL, Roberts WE, Starker I, Wang B. Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing. J Clin Aesthet Dermatol 2010; 3: 32-43.
18. Kumari R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melisma. Indian J Dermatol 2010; 76: 447.
19. Sarkar R, Kaur C, Bhalla M, Kanwar AJ. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Dermatol Surg 2002; 28: 828-832.
20. Fabbrocini G, De Padova MP, Tosti A. Chemical peels: what's new and what isn't new but still works well. Facial Plast Surg 2009; 25: 329-336.
21. Pandya AG, Hynan LS, Bhore R, Riley FC. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol 2011; 64: 78-83.
22. Gupta G, Mallefet P, Kress DW, Sergeant A. Adherence to topical dermatological therapy: lessons from oral drug treatment. Br J Dermatol 2009; Aug 161: 221-227.